Relationship between diazepam dose, plasma level, age, and central nervous system depression.
about
Hypnotic accumulation and hangover in elderly inpatients: a controlled double-blind study of temazepam and nitrazepamPotential drug-drug interactions in Alzheimer patients with behavioral symptomsMedications in older patientsMedication and the elderly. Issues of prescription and use.Drug prescribing for the elderly.Strategies for optimizing antiepileptic drug therapy in elderly people.Single dose pharmacokinetics and pharmacodynamics of oral oxazepam in very elderly institutionalised subjectsSingle dose pharmacokinetics and pharmacodynamics of oral loprazolam in the elderly.Responsiveness to oral diazepam in the elderly: relationship to total and free plasma concentrations.Benzodiazepines in clinical medicine: discussion.Midazolam dosage studies in institutionalized geriatric patientsBenzodiazepine poisoning: experience of 702 admissions to an intensive care unit during a 14-year period.Diazepam tolerance: effect of age, regular sedation, and alcohol.Drug discontinuation effects are part of the pharmacology of a drugLigand binding to the FA3-FA4 cleft inhibits the esterase-like activity of human serum albuminAge-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.Drugs in the elderly.Pharmacodynamics of the anticonvulsant effect of oxazepam in aging BN/BiRij rats.Medications and the safety of the older driver: is there a basis for concern?The critical role of clinical pharmacology in geriatric psychopharmacology.Association between falls and high-risk medication use in hospitalized Asian elderly patients.Pharmacodynamic issues relevant to geriatric psychopharmacology.Prescribing for older adults.Improving medication prescribing and utilization in the nursing home.Implications of altered drug disposition in the elderly: studies of benzodiazepines.'Healthy' prescribing for the elderly. How to minimize adverse drug effects and prevent 'dementia in a bottle'.Benzodiazepine kinetics: implications for therapeutics and pharmacogeriatrics.Adverse drug reactions among the elderly: a reassessment.Pharmacology and aging.Neuropsychiatric implications of thyroid hormone and benzodiazepine interactions.Factors and conditions affecting the glucuronidation of oxazepam.Age-related increase in CNS sensitivity to benzodiazepines as assessed by task difficulty.Drug use in a geriatric population.Polypharmacy in the Elderly: Drug reactions and interaction in the aged.Kinetics of nicotinic acetylcholine ion channels in the presence of intravenous anaesthetics and induction agents.Prescribing drugs for the elderly: reaching therapeutic goals.Dose Dependencies and Biocompatibility of Renal Clearable Gold Nanoparticles: From Mice to Non-human Primates.Pharmacodynamics and pharmacokinetics of ethanol, diazepam and pentobarbital in young and aged rats.From adverse drug reactions to drug disposition to WHO and essential medicines to our discipline of clinical pharmacology.Long-term intravenous and oral flumazenil treatment of acute diazepam overdose in an older patient.
P2860
Q24675854-F22AEC19-4194-45DA-8183-DC3467CCA500Q26782490-4665079F-912B-4329-B63D-B40F045EC9B4Q33606758-71746F0B-EE4C-4F1A-996E-19CE4FFFDE04Q33630080-4D4ED646-AD8D-4DCD-8F77-D20D97CF5D8BQ34110511-46E7D069-14AA-45F8-8F28-013AAEE7D5BCQ34118987-B6691189-624F-4210-B979-2FCC2286C1EFQ34358937-BF9BDA66-1668-49DE-AED8-C819DB0FC6BFQ34446648-B8833014-B48B-4713-A507-DF4E43BA0800Q34446670-F9C178D5-BA49-41C8-BE7D-7634F5CEC99CQ34448689-48A5F52C-0875-482C-9CE9-B0B3E3F870B0Q34513587-233ECBBB-7BFB-4E30-AEE5-DBBE9CEF9CFCQ34541667-02560286-82F2-467A-9242-500B0F16F1A5Q34551342-C50E9823-B574-4087-8958-186C896F7DD6Q35430065-8546DCEF-54FD-49F3-88E5-3B7CF4B47762Q35581476-3D42BE47-77BA-4C37-9C4B-C2C6B4714553Q35608904-885B625B-6E55-400F-AB01-8225AC4BCD3EQ35651099-85557E7F-D787-4A46-8CF9-36B72A51D06FQ35870770-26CCABA5-612A-4CB7-A37F-B57BA0462A53Q36073478-2EF125E3-1A7C-4B13-93A9-B21DD0564943Q37335839-A7C9F516-F4C2-4C6F-AD49-8E5F778E2AE9Q37585545-9F74E960-1231-4D56-A849-7998042FFE96Q37781948-256E3FE1-3E23-45DE-80CD-1C2C0514A955Q37900254-27760852-4FA8-45D8-87EC-25DCC3DFAF6FQ37919728-F5202976-4076-4C1D-BBE1-3A8A8A7B52DDQ38367876-E080BF3F-0923-4F37-9D0C-8C1E596AFFFCQ39675846-634782A8-148C-4669-97A6-69987AE84FF0Q40206942-2E9DBC0C-A78C-44B1-BC39-619033BFE0E3Q40318373-A5C044E6-ECCF-4732-927F-7C102DC85CA6Q40326082-1D5AD58B-944D-4D46-AE14-6CCFE89A3B9BQ40852689-9A836D2E-5E8E-4F22-B156-DE3BC5F56C9BQ40866617-E2CB5536-07B8-40D8-8A23-D963BF4D664FQ41173265-BB015939-0063-484A-B317-5B9547EEC551Q41688728-14ED25DA-C8B6-4732-87A0-5A9857F1A699Q41965300-0FEBCA95-6B1A-4096-8844-74EB9C5C5CEFQ42073200-D55EA1C9-1B46-4CFD-B937-CEC71ECAB931Q43157610-3DC95E56-28FB-4CCE-9427-A5819E1DBDAFQ47827353-5F124723-8783-436C-B9FD-FA74BF078FDCQ48187909-FB6FFF84-6475-4576-9E62-740221A5EB5EQ48310225-09894219-2E30-4643-BBCA-78B7781CFDB7Q51570743-EA4F359C-1ADC-46AB-8365-79C6C88270DD
P2860
Relationship between diazepam dose, plasma level, age, and central nervous system depression.
description
1978 nî lūn-bûn
@nan
1978 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1978 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
name
Relationship between diazepam ...... ral nervous system depression.
@ast
Relationship between diazepam ...... ral nervous system depression.
@en
Relationship between diazepam ...... ral nervous system depression.
@nl
type
label
Relationship between diazepam ...... ral nervous system depression.
@ast
Relationship between diazepam ...... ral nervous system depression.
@en
Relationship between diazepam ...... ral nervous system depression.
@nl
prefLabel
Relationship between diazepam ...... ral nervous system depression.
@ast
Relationship between diazepam ...... ral nervous system depression.
@en
Relationship between diazepam ...... ral nervous system depression.
@nl
P2093
P356
P1476
Relationship between diazepam ...... ral nervous system depression.
@en
P2093
Cheripko J
Coutinho CB
Reidenberg MM
Schwartz MA
P304
P356
10.1002/CPT1978234371
P407
P577
1978-04-01T00:00:00Z